#United States #Oakland #PURELL #GOJO Industries #Clorox

Clorox Company Q3 Fiscal Year 2026 Results Overview

On April 30, 2026, The Clorox Company (NYSE: CLX) released its financial results for the third quarter of fiscal year 2026, which came to a close on March 31, 2026. This quarter showed net sales of $1.67 billion, staying flat compared to the previous fiscal year's third quarter.

Key Financial Highlights:

• - Organic Sales: There was a slight decrease of 1% in organic sales.
• - Gross Margin: The gross margin dropped to 43.2%, a decline of 140 basis points from the previous year’s 44.6%. This drop was primarily driven by increased manufacturing costs and logistical challenges, though cost-saving measures partially alleviated the impact.
• - Earnings Per Share (EPS): The diluted EPS witnessed a 3% growth, reaching $1.54, which reflects various adjustments including investments related to digital capabilities. Adjusted EPS, which provides a clearer picture by excluding unusual costs, increased by 13% to $1.64.

Strategic Highlights and Segments Performance

Clorox's Chair and CEO, Linda Rendle, commented on the mixed results: "We see ongoing momentum in several segments, yet are facing challenges in market share recovery in others." The company is committed to enhancing execution in lower-performing areas while also reinforcing strong segments.

Acquisition of GOJO Industries: A critical development during this quarter was the completion of the acquisition of GOJO Industries on April 1, 2026. This move significantly expands Clorox's portfolio to include the well-known Purell® hand sanitizer brand, aligning with their long-term strategy of enhancing health and hygiene product offerings.

Product Innovations: Clorox has also been actively focusing on innovation across its product lines. Recent activities included the introduction of new offerings in food and personal care segments, and expanding their successful brands such as Hidden Valley and Burt's Bees. The launch of Clorox PURE is noteworthy, as it exceeded initial sales expectations shortly after its debut.

Segment Overview

Analyzing the performance across its segments:

• - Health and Wellness: Net sales remained stable, despite logistical challenges impacting costs and pricing strategies.
• - Household Products: Experienced a 3% increase in sales driven by a spike in demand for Grilling and Cat Litter products.
• - Lifestyle Products: Faced a 9% decline largely due to reduced consumer engagement and adjustments in retail inventory.
• - International Sales: Enjoyed an 8% increase, benefiting from favorable foreign exchange rates.

Outlook for Fiscal Year 2026

Moving forward, Clorox has updated its outlook for fiscal year 2026, reflecting the recent performances and acquisition impacts. They anticipate a 6% decrease in net sales, accounting for various market dynamics including adverse effects from the inventory adjustments in the previous fiscal year related to their ERP transition. Expecting organic sales declines of about 9%, the company also predicts a decline in gross margins of 250 to 300 basis points due to operational costs and strategic investments in digital capabilities.

The anticipated diluted EPS range for FY 2026 stands between $4.78 and $4.98, a notable decrease compared to previous projections. The adjusted EPS forecast, factoring organic growth and the GOJO deal, is expected to fall between $5.45 and $5.65.

Conclusion

Despite facing a challenging economic landscape, Clorox remains optimistic about its strategic directions, primarily focusing on innovation, market share enhancement, and profitable growth. With the integration of GOJO Industries now in motion, stakeholders await further developments as Clorox navigates through the upcoming fiscal year. As Rendle stated, “We believe our committed efforts in innovation and strategic investments will pave the way for consistent growth.”

For more detailed insights on Clorox's operations and future directions, visit thecloroxcompany.com.